Literature DB >> 28379395

Role of Growth Hormone in Breast Cancer.

Ramadevi Subramani1, Sushmita B Nandy1, Diego A Pedroza2, Rajkumar Lakshmanaswamy1,2.   

Abstract

Breast cancer is one of the most common cancers diagnosed in women. Approximately two-thirds of all breast cancers diagnosed are classified as hormone dependent, which indicates that hormones are the key factors that drive the growth of these breast cancers. Ovarian and pituitary hormones play a major role in the growth and development of normal mammary glands and breast cancer. In particular, the effect of the ovarian hormone estrogen has received much attention in regard to breast cancer. Pituitary hormones prolactin and growth hormone have also been associated with breast cancer. Although the role of these pituitary hormones in breast cancers has been studied, it has not been investigated extensively. In this review, we attempt to compile basic information from most of the currently available literature to understand and demonstrate the significance of growth hormone in breast cancer. Based on the available literature, it is clear that growth hormone plays a significant role in the development, progression, and metastasis of breast cancer by influencing tumor angiogenesis, stemness, and chemoresistance.
Copyright © 2017 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28379395     DOI: 10.1210/en.2016-1928

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

Review 1.  Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer.

Authors:  John J Kopchick; Reetobrata Basu; Darlene E Berryman; Jens O L Jorgensen; Gudmundur Johannsson; Vishwajeet Puri
Journal:  Nat Rev Endocrinol       Date:  2022-06-24       Impact factor: 47.564

2.  Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway.

Authors:  Qing Robert Miao; Ying Jin; Zhimin Fan; Chang Liu; Sijie Li; Xiaoxiao Zhang; Chunxiang Jin; Baofeng Zhao; Liying Li
Journal:  Cancer Gene Ther       Date:  2022-10-14       Impact factor: 5.854

Review 3.  Drug Repurposing by Tumor Tissue Editing.

Authors:  Florian Lüke; Dennis Christoph Harrer; Pan Pantziarka; Tobias Pukrop; Lina Ghibelli; Christopher Gerner; Albrecht Reichle; Daniel Heudobler
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

4.  Idiopathic gigantomastia: newer mechanistic insights implicating the paracrine milieu.

Authors:  Liza Das; Ashutosh Rai; Kim Vaiphei; Akhil Garg; Subair Mohsina; Anil Bhansali; Pinaki Dutta; Satyaswarup Tripathy
Journal:  Endocrine       Date:  2019-09-09       Impact factor: 3.633

5.  The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH?

Authors:  Edward O List; Darlene E Berryman; Reetobrata Basu; Mathew Buchman; Kevin Funk; Prateek Kulkarni; Silvana Duran-Ortiz; Yanrong Qian; Elizabeth A Jensen; Jonathan A Young; Gozde Yildirim; Shoshana Yakar; John J Kopchick
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

6.  Common pathways and functional profiles reveal underlying patterns in Breast, Kidney and Lung cancers.

Authors:  Sergio Romera-Giner; Zoraida Andreu Martínez; Francisco García-García; Marta R Hidalgo
Journal:  Biol Direct       Date:  2021-05-26       Impact factor: 4.540

7.  Role of sex hormones in modulating breast and ovarian cancer associated pain.

Authors:  Melissa C McHann; Henry L Blanton; Josée Guindon
Journal:  Mol Cell Endocrinol       Date:  2021-05-24       Impact factor: 4.369

8.  Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer.

Authors:  XiaoDan Mao; Binhua Dong; Min Gao; GuanYu Ruan; MeiMei Huang; Elena Ioana Braicu; Jalid Sehouli; PengMing Sun
Journal:  Onco Targets Ther       Date:  2019-08-20       Impact factor: 4.147

9.  Mammary Tumors Growing in the Absence of Growth Hormone Are More Sensitive to Doxorubicin Than Wild-Type Tumors.

Authors:  Daniel D Lantvit; Christopher J Unterberger; Michelle Lazar; Paige D Arneson; Colin A Longhurst; Steven M Swanson; Paul C Marker
Journal:  Endocrinology       Date:  2021-04-01       Impact factor: 4.736

Review 10.  The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies.

Authors:  Silvana Duran-Ortiz; Alison L Brittain; John J Kopchick
Journal:  Clin Proteomics       Date:  2017-06-29       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.